# Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/early-cost-effectiveness-analysis-of-using-whole-genome-sequencing-for-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jinjing Fu,Nora Franzen,Eline Aas,J C Koen van der Mijn,Pim J. van Leeuwen,Valesca P. Retèl |
| Citations | 4 |
| DOI | 10.1016/j.jval.2025.02.004 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pure.eur.nl/ws/files/189859784/1-s2.0-S1098301525000828-main.pdf |
| OpenAlex ID | https://openalex.org/W4408129111 |
| PMID | 40049327 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Nora Franzen](https://scholariq.org/researchers/nora-franzen/)

## Paper journal

- [Value in Health](https://scholariq.org/journals/value-in-health/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.